Project NeoVitaA – A prospective, multicenter, double blind, placebo-controlled, two-arm parallel group phase 3 trialto…

Basic data

Acronym:
NeoVitaA
Title:
A prospective, multicenter, double blind, placebo-controlled, two-arm parallel group phase 3 trialto evaluate the effect of early postnatal additional high dose oral vitamin A supplementation of5000 IU/kg/d versus placebo for 28 days for preventing bronchopulmonary dysplasia (BPD) ordeath in extremely low birth weight (ELBW) infants.
Duration:
20/04/2016 to 20/04/2018
Abstract / short description:
The aim of this trial is to assess the role of early postnatal additional high-dose oral Vitamin A supplementation versus placebo for 28 days for preventing BPD or death in ELBW infants.
Keywords:
pediatrics
Pädiatrie

Involved staff

Managers

University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Faculty of Medicine
University of Tübingen

Local organizational units

Paediatrics Department IV
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine

Funders

Saarbrücken, Saarland, Germany
Help

will be deleted permanently. This cannot be undone.